Newsroom

David E. Anderson, Ph.D., discusses updated Part B data from the VBI's ongoing Phase 1/2a study of VBI-1901.

Hepatitis B is a disease of the liver caused by the hepatitis B virus (“HBV”) characterized by inflammation, injury, and even cell death.

VBI’s eVLP Platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines.